Christopher David

520 total citations
16 papers, 165 citations indexed

About

Christopher David is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Christopher David has authored 16 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Christopher David's work include Nanoparticles: synthesis and applications (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Extracellular vesicles in disease (2 papers). Christopher David is often cited by papers focused on Nanoparticles: synthesis and applications (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Extracellular vesicles in disease (2 papers). Christopher David collaborates with scholars based in United Kingdom, United States and Netherlands. Christopher David's co-authors include Neill J. Liptrott, Andrew Owen, Rob J. Vandebriel, Fanny Caputo, Marco Siccardi, Sven Even Borgos, Susanne Bremer‐Hoffmann, Blanka Halamoda‐Kenzaoui, Matteo Santin and Patricia Murray and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Molecular Sciences and Journal of Controlled Release.

In The Last Decade

Christopher David

16 papers receiving 161 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher David United Kingdom 7 48 41 34 30 30 16 165
Junfu Zhang China 10 71 1.5× 78 1.9× 65 1.9× 24 0.8× 13 0.4× 25 278
Yongjun Li China 5 23 0.5× 28 0.7× 37 1.1× 26 0.9× 9 0.3× 15 157
Huiyang Wang China 9 116 2.4× 47 1.1× 112 3.3× 24 0.8× 118 3.9× 21 344
Susan Hershenson United States 9 191 4.0× 14 0.3× 31 0.9× 20 0.7× 29 1.0× 14 327
Wu Shun Felix Wong Australia 9 40 0.8× 68 1.7× 117 3.4× 41 1.4× 16 0.5× 19 397
Samina Afzal Canada 10 90 1.9× 26 0.6× 15 0.4× 5 0.2× 15 0.5× 15 283
Leonie Helder Netherlands 6 33 0.7× 33 0.8× 21 0.6× 6 0.2× 72 2.4× 11 189
Chunxia Zhu China 12 68 1.4× 17 0.4× 22 0.6× 29 1.0× 9 0.3× 18 323
John Desjardins United States 11 159 3.3× 34 0.8× 18 0.5× 7 0.2× 14 0.5× 13 304

Countries citing papers authored by Christopher David

Since Specialization
Citations

This map shows the geographic impact of Christopher David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher David more than expected).

Fields of papers citing papers by Christopher David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher David. The network helps show where Christopher David may publish in the future.

Co-authorship network of co-authors of Christopher David

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher David. A scholar is included among the top collaborators of Christopher David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher David. Christopher David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Rendra, Erika, Christopher David, Karen Bieback, et al.. (2023). Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitro. Biomedicine & Pharmacotherapy. 167. 115624–115624. 3 indexed citations
2.
Pennington, Shaun H., Christopher David, Giancarlo A. Biagini, et al.. (2023). Age-differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection - Effects of vitamin D. Mucosal Immunology. 16(6). 776–787. 4 indexed citations
3.
David, Christopher, et al.. (2023). Application of KU812 cells for assessing complement activation related effects by nano(bio)materials. Biomedicine & Pharmacotherapy. 163. 114841–114841. 1 indexed citations
4.
Curley, Paul, Neill J. Liptrott, Edward Makarov, et al.. (2023). Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations. Pharmaceutics. 15(7). 1835–1835. 3 indexed citations
5.
Vandebriel, Rob J., Christopher David, Jolanda P. Vermeulen, & Neill J. Liptrott. (2022). An inter-laboratory comparison of an NLRP3 inflammasome activation assay and dendritic cell maturation assay using a nanostructured lipid carrier and a polymeric nanomedicine, as exemplars. Drug Delivery and Translational Research. 12(9). 2225–2242. 4 indexed citations
8.
Arshad, Usman, Henry Pertinez, Helen Box, et al.. (2021). Scalable nanoprecipitation of niclosamide and in vivo demonstration of long-acting delivery after intramuscular injection. Nanoscale. 13(13). 6410–6416. 14 indexed citations
9.
Halamoda‐Kenzaoui, Blanka, Rob J. Vandebriel, Marco Siccardi, et al.. (2021). Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation. Journal of Controlled Release. 336. 192–206. 54 indexed citations
10.
David, Christopher, M. Estela del Castillo Busto, Heidi Goenaga‐Infante, et al.. (2021). Assessment of changes in autophagic vesicles in human immune cell lines exposed to nano particles. Cell & Bioscience. 11(1). 133–133. 3 indexed citations
11.
Arshad, Usman, et al.. (2021). Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Advanced Drug Delivery Reviews. 178. 113848–113848. 10 indexed citations
12.
David, Christopher, Michael Barrow, Patricia Murray, et al.. (2020). In Vitro Determination of the Immunogenic Impact of Nanomaterials on Primary Peripheral Blood Mononuclear Cells. International Journal of Molecular Sciences. 21(16). 5610–5610. 11 indexed citations
13.
David, Christopher, Andrew Owen, & Neill J. Liptrott. (2016). Determining the Relationship between Nanoparticle Characteristics and Immunotoxicity: Key Challenges and Approaches. Nanomedicine. 11(11). 1447–1464. 25 indexed citations
14.
David, Christopher, Andreas Stahl, Ken‐ichi Hirata, et al.. (2004). Endothelial lipase is synthesized by hepatic and aorta endothelial cells and its expression is altered in apoE-deficient mice. Journal of Lipid Research. 45(9). 1614–1623. 19 indexed citations
15.
Lee, Sung‐Joon, et al.. (2004). Association of hepatic lipase with proteoglycans stimulates the production of proteoglycans in vivo and in vitro. Journal of Lipid Research. 45(7). 1266–1271. 3 indexed citations
16.
Lee, Sung‐Joon, et al.. (2004). Removal of chylomicron remnants in transgenic mice overexpressing normal and membrane-anchored hepatic lipase. Journal of Lipid Research. 46(1). 27–35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026